CONMED CNMD Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 54.6%-1.5pp | 56.1%+1.8pp | 54.3%-0.3pp | 54.6%-1.6pp | |
| Operating margin | 7.5%-7.9pp | 15.3%+5.6pp | 9.7%+2.9pp | 6.8%-4.1pp | |
| Net margin | 3.4%-6.7pp | 10.1%+5.0pp | 5.2%— | —— | |
| Returns | |||||
| Return on equity | 4.7%-10.0pp | 14.7%+6.6pp | 8.2%— | —— | |
| Return on invested capital | 3.6%-5.2pp | 8.8%+3.6pp | 5.2%+1.0pp | 4.3%-2.1pp | |
| Efficiency | |||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.5×0.0× | 0.5×-0.1× | |
| Liquidity | |||||
| Current ratio | 2.1×-0.2× | 2.3×+0.3× | 2×0.0× | 2×-0.4× | |
| Leverage | |||||
| Debt-to-equity | 0.9×-0.1× | 1×-0.2× | 1.2×-0.3× | 1.5×+0.6× | |
| Net debt / EBITDA | 5.5×+1.8× | 3.7×-2.0× | 5.6×-3.6× | 9.2×+4.8× | |
| Per Share | |||||
| Book value per share | $33.17+7.3% | $30.90+16.9% | $26.44+6.5% | $24.82+1.8% | |
| Valuation | |||||
| Market capitalization | $1.04B-35.6% | $2.11B-37.2% | $3.37B+24.6% | $2.7B-34.8% | |
| Price / earnings | 19×+5.4× | 16×-36.3× | 52.2×— | —— | |
| Price / sales | 0.8×-0.5× | 1.6×-1.1× | 2.7×+0.1× | 2.6×-1.5× | |
| Price / book | 1×-0.6× | 2.2×-1.8× | 4×+0.4× | 3.6×-1.7× | |
| EV / EBITDA | 11.4×+0.7× | 12.1×-13.1× | 25.2×-6.3× | 31.6×+1.2× | |
| Dividend yield | 1.8%+0.3pp | 1.2%+0.4pp | 0.7%-0.2pp | 0.9%+0.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CONMED's profit margins?
- CONMED (CNMD) runs a 55.2% gross margin and a 8.2% operating margin, with a 4.0% net margin.
- Where do CONMED's ratios come from?
- Every ratio is computed from CONMED's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
